Cite
Novel recombinant coxsackievirus B3 with genetically inserted basic peptide elicits robust antitumor activity against lung cancer.
MLA
Cai, Ligang, and Zhiyi Liu. “Novel Recombinant Coxsackievirus B3 with Genetically Inserted Basic Peptide Elicits Robust Antitumor Activity against Lung Cancer.” Cancer Medicine, vol. 9, no. 14, July 2020, pp. 5210–20. EBSCOhost, https://doi.org/10.1002/cam4.3143.
APA
Cai, L., & Liu, Z. (2020). Novel recombinant coxsackievirus B3 with genetically inserted basic peptide elicits robust antitumor activity against lung cancer. Cancer Medicine, 9(14), 5210–5220. https://doi.org/10.1002/cam4.3143
Chicago
Cai, Ligang, and Zhiyi Liu. 2020. “Novel Recombinant Coxsackievirus B3 with Genetically Inserted Basic Peptide Elicits Robust Antitumor Activity against Lung Cancer.” Cancer Medicine 9 (14): 5210–20. doi:10.1002/cam4.3143.